EDGAR Filing Documents for 0001193125-18-341645

Form 8-K - Current report:

SEC Accession No. 0001193125-18-341645

Filing Date

2018-12-04

Accepted

2018-12-04 08:14:11

Documents

Period of Report

2018-12-04

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d668154d8k.htm	8-K	34296
2	EX-99.1	d668154dex991.htm	EX-99.1	34950
3	EX-99.2	d668154dex992.htm	EX-99.2	38972
4	GRAPHIC	g668154ex99_2s10g1.jpg	GRAPHIC	244292
5	GRAPHIC	g668154ex99_2s11g1.jpg	GRAPHIC	199556
6	GRAPHIC	g668154ex99_2s12g1.jpg	GRAPHIC	173989
7	GRAPHIC	g668154ex99_2s13g1.jpg	GRAPHIC	216913
8	GRAPHIC	g668154ex99_2s14g1.jpg	GRAPHIC	222855
9	GRAPHIC	g668154ex99_2s15g1.jpg	GRAPHIC	283719
10	GRAPHIC	g668154ex99_2s16g1.jpg	GRAPHIC	246593
11	GRAPHIC	g668154ex99_2s17g1.jpg	GRAPHIC	344978
12	GRAPHIC	g668154ex99_2s18g1.jpg	GRAPHIC	306980
13	GRAPHIC	g668154ex99_2s19g1.jpg	GRAPHIC	209098
14	GRAPHIC	g668154ex99_2s1g1.jpg	GRAPHIC	466378
15	GRAPHIC	g668154ex99_2s20g1.jpg	GRAPHIC	210002
16	GRAPHIC	g668154ex99_2s21g1.jpg	GRAPHIC	213986
17	GRAPHIC	g668154ex99_2s22g1.jpg	GRAPHIC	251144
18	GRAPHIC	g668154ex99_2s23g1.jpg	GRAPHIC	245633
19	GRAPHIC	g668154ex99_2s24g1.jpg	GRAPHIC	225444
20	GRAPHIC	g668154ex99_2s25g1.jpg	GRAPHIC	196258
21	GRAPHIC	g668154ex99_2s26g1.jpg	GRAPHIC	221420
22	GRAPHIC	g668154ex99_2s27g1.jpg	GRAPHIC	309115
23	GRAPHIC	g668154ex99_2s28g1.jpg	GRAPHIC	286874
24	GRAPHIC	g668154ex99_2s29g1.jpg	GRAPHIC	297100
25	GRAPHIC	g668154ex99_2s2g1.jpg	GRAPHIC	666927
26	GRAPHIC	g668154ex99_2s30g1.jpg	GRAPHIC	412158
27	GRAPHIC	g668154ex99_2s31g1.jpg	GRAPHIC	378738
28	GRAPHIC	g668154ex99_2s32g1.jpg	GRAPHIC	402394
29	GRAPHIC	g668154ex99_2s33g1.jpg	GRAPHIC	386561
30	GRAPHIC	g668154ex99_2s34g1.jpg	GRAPHIC	280807
31	GRAPHIC	g668154ex99_2s35g1.jpg	GRAPHIC	322391
32	GRAPHIC	g668154ex99_2s36g1.jpg	GRAPHIC	267782
33	GRAPHIC	g668154ex99_2s37g1.jpg	GRAPHIC	395042
34	GRAPHIC	g668154ex99_2s3g1.jpg	GRAPHIC	303876
35	GRAPHIC	g668154ex99_2s4g1.jpg	GRAPHIC	328767
36	GRAPHIC	g668154ex99_2s5g1.jpg	GRAPHIC	305269
37	GRAPHIC	g668154ex99_2s6g1.jpg	GRAPHIC	280168
38	GRAPHIC	g668154ex99_2s7g1.jpg	GRAPHIC	270118
39	GRAPHIC	g668154ex99_2s8g1.jpg	GRAPHIC	265484
40	GRAPHIC	g668154ex99_2s9g1.jpg	GRAPHIC	293374
41	GRAPHIC	g668154g1204114704376.jpg	GRAPHIC	3883
	Complete submission text file	0001193125-18-341645.txt		15175541

Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560

Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400

Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)